openPR Logo
Press release

Deadline in Lawsuit on May 5th coming up for Investors in PharmaCielo Ltd. (OTC: PCLOF)

05-02-2020 01:25 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on May 5, 2020 in the lawsuit for certain investors in PharmaCielo Ltd. (OTC: PCLOF).

A Deadline is coming up on May 5, 2020 in the lawsuit for certain investors in PharmaCielo Ltd. (OTC: PCLOF).

A deadline is coming up on May 5, 2020 in the lawsuit filed for certain investors of PharmaCielo Ltd. (OTC: PCLOF) over alleged securities laws violations by PharmaCielo Ltd.

Investors who purchased shares of PharmaCielo Ltd. (OTC: PCLOF) have certain options and there are strict and short deadlines running. Deadline: HHHHH. OTC: PCLOF stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on behalf of purchasers of PharmaCielo Ltd. (OTC: PCLOF) common shares between June 21, 2019 and March 2, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 21, 2019 and March 2, 2020, the defendants made false and/or misleading statements and/or failed to disclose that PharmaCielo engaged in an undisclosed related party transactions with General Extract LLC, that PharmaCielo engaged in misleading transactions and loans with General Extract LLC and XPhyto Therapeutics Corp., that PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed, that the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants, that PharmaCielo's Cauca Department land has never been utilized by the Company and is idle, and that as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of PharmaCielo Ltd. (OTC: PCLOF) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline in Lawsuit on May 5th coming up for Investors in PharmaCielo Ltd. (OTC: PCLOF) here

News-ID: 2032113 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for PharmaCielo

Advanced Cancer Pain Management Market Share & Size Analysis, Growth, Trends, Re …
According to a new report published by CoherentMI The Global Advanced Cancer Pain Management Market is estimated to be valued at USD 8.1 Bn in 2024 and is expected to reach USD 12.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031. Most recent Report, named "Advanced Cancer Pain Management Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI
Colombia Hemp Market to Reach USD 413 Mn by 2029, emerging at a CAGR of 20 perce …
Colombia Hemp Market Report Scope: This report presents a detailed exploration of the Colombia hemp industry, offering vital insights into the dynamic market. The report encompasses growth drivers, challenges, and regional insights that contribute to the thriving hemp industry in Colombia. Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/188525 Colombia Hemp Market Research Methodology: The findings in this report are drawn from a thorough research methodology that combines primary and secondary data
Medical Cannabi-s Market Will Generate Record Revenue by 2029
The report presents detailed information regarding the prominent players and potential competitors in the Medical Cannabi-s market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player. This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue, growth rate,
Europe Medical Can-nabis Market Forecast to 2028 - COVID-19 Impact and Regional …
Rising Research Activities on Medicinal Use of Can-nabis to Drive Europe Medical Can-nabis Market For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2353/europe-medical-can-nabis-market According to a new research study titled ""Europe Medical Can-nabis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Medical Application, and Compound,"" the market is expected to grow from US$ 492.1 million in 2021 to US$ 13,801.0 million by 2028. It is
Colombia Hemp Market 2022: Trends, Growth, Analysis, Size and Future Scope 2027
According to the latest report by IMARC Group, titled "Colombia Hemp Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," The Colombia hemp market is expected to exhibit a CAGR of 20.1% during 2022-2027. Report Metric Historical: 2016-2021 Base Year: 2021 Forecast Year: 2022-2027 Download free sample of the report: https://www.imarcgroup.com/colombia-hemp-market/requestsample Colombia Hemp Market Industry Definition and Application: Hemp refers to plant fiber that contains a low level of tetrahydrocannabinol (THC). It is generally used in the
Investigation for Long-Term Investors in shares of PharmaCielo Ltd. (OTC: PCLOF) …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PharmaCielo Ltd.. Investors who are current long term investors in PharmaCielo Ltd. (OTC: PCLOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in OTC: PCLOF stocks follows a lawsuit filed against PharmaCielo Ltd. over